ELCC 2019 | A STELLAR study: TTFields for malignant pleural mesothelioma

Name: A STELLAR study: TTFields for malignant pleural mesothelioma
Uploaded: 2019-04-01T00:00:00.000Z
Duration: 2 min 3 s
Description: In this interview, Ori Farber, MD, of Novocure, Haifa, Israel, discusses the promising results of the STELLAR study (NCT02397928) utilizing tumor treating fields (TTF) for the treatment of malignant pleural mesothelioma. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.

Ori Farber • 1 Apr 2019

ELCC 2019

Mesothelioma

STELLAR

In this interview, Ori Farber, MD, of Novocure, Haifa, Israel, discusses the promising results of the STELLAR study (NCT02397928) utilizing tumor treating fields (TTF) for the treatment of malignant pleural mesothelioma. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.